Emil Pot has more than 20 years of experience in technology transfer and biotech start-up companies. He is the co-founder of ActoGenix, IP expert at NLO, Business Devevelopment at Oncode Institute and co-founder of Allero Therapeutics.
Emil has obtained a LL.M. from University of Groningen, studied life sciences while at VIB and is a qualified European Patent Attorney.
- Business development